Phase II Clinical Study of PLM60 for the Treatment of Cutaneous T Cell Lymphomas
Clinical trial NCT02597153 · TERMINATED
Trial details
- NCT number
- NCT02597153
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2017-10-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.